Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
APMIS ; 114(6): 420-7, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16856963

ABSTRACT

Gene product expression in normal and chronic hepatitis C virus infection was determined in an attempt to improve our understanding of the molecular events leading to the development of cirrhosis and liver carcinoma. Activation of CD95 (Fas) causes apoptosis of cells and liver failure in mice and has been associated with human liver disorders. c-myc is involved in cell proliferation and EGFR in regeneration of cells. The material of the current study included 50 cases of chronic hepatitis C (CHC) (and negative hepatitis B virus infection), 29 cases of liver cirrhosis and HCV (LC), and 19 cases of hepatocellular carcinoma and HCV (HCC) admitted to the Theodor Bilharz Research Institute (TBRI) during the years 2003-2004. Ten wedge liver biopsies - taken during laparoscopic cholecystectomy - were included in the study as normal controls. Laboratory investigations, including liver function tests, serological markers for viral hepatitis and serum alpha fetoprotein level (alpha-FP), were determined for all cases. Histopathological study and immunohistochemistry using monoclonal antibodies for CD95, c-myc and EGFR were also done. In CHC cases, the histological activity index (HAI) revealed more expression of Fas antigen in liver tissues with active inflammation than in those without active inflammation (p < 0.01). EGFR and c-myc act synergistically in liver tumorigenesis. Upregulation of Fas in chronic hepatitis C infection and of c-myc & EGFR in malignant transformation was concluded from this study. c-myc expression may obstruct the induction of apoptosis of HCC cells and lead to uncontrolled cell growth.


Subject(s)
Carcinoma, Hepatocellular/metabolism , ErbB Receptors/biosynthesis , Hepatitis C, Chronic/metabolism , Liver Cirrhosis/metabolism , Liver Neoplasms/metabolism , Proto-Oncogene Proteins c-myc/biosynthesis , fas Receptor/biosynthesis , Adult , Biopsy , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/virology , Female , Hepacivirus , Hepatitis C, Chronic/pathology , Hepatitis C, Chronic/virology , Humans , Immunohistochemistry , Liver Cirrhosis/pathology , Liver Cirrhosis/virology , Liver Neoplasms/pathology , Liver Neoplasms/virology , Male , Middle Aged
2.
APMIS ; 109(5): 376-82, 2001 May.
Article in English | MEDLINE | ID: mdl-11478685

ABSTRACT

In this work, the changes in expression of the adhesion molecules ICAM-1/LFA-1 on inflammatory cells of the liver were studied by immunohistochemistry. Mice sensitized with SEA and infected with S. mansoni and S. mansoni-infected controls were examined from day 35 to day 56 postinfection. A significant upregulation of ICAM-1 and LFA-1 in both the SEA group and the infected control group started shortly after egg deposition at day 35 and persisted up to day 56 p.i. Notably, both ICAM-1 and LFA-1 expression peaks were shifted earlier to day 38 p.i. in the SEA group compared to day 40 in the infected control group. The distribution of ICAM-1 and LFA-1 in both groups was comparable. At the early phase of infection before granuloma formation, both ICAM-1 and LFA-1 were detected along the sinusoidal wall of small blood vessels. At the acute cellular granuloma phase, they were homogeneously distributed all over the inflammatory cells, while at the chronic fibrocellular stage a non-homogeneous staining of granuloma cells at the periphery of the granuloma was apparent. The present data suggest that adhesion molecules play a role in the initiation and maintenance of granuloma formation. Thus, the granulomatous hyporesponsiveness induced by sensitization with SEA was associated with reduced expression of adhesion molecules.


Subject(s)
Antigens, Helminth/immunology , Granuloma/pathology , Intercellular Adhesion Molecule-1/analysis , Lymphocyte Function-Associated Antigen-1/analysis , Schistosoma mansoni/immunology , Schistosomiasis mansoni/pathology , Animals , Female , Granuloma/parasitology , Immunohistochemistry , Mice , Mice, Inbred C57BL , Ovum/immunology , Time Factors
3.
Int J Parasitol ; 30(7): 837-42, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10899528

ABSTRACT

This work studied the histopathological changes and the changes in the expression of macrophage adhesion molecule-1 (Mac-1) and macrophage inflammatory protein-1alpha (MIP-1alpha) in a murine model of soluble egg antigen (SEA) - induced granulomatous hyporesponsiveness. Histopathological results of hepatic sections in an SEA group showed early acceleration of ova destruction and markedly diminished granuloma cellularity with eosinophils and macrophages still being the predominant cells. Later, giant cells and pigmented macrophages that were scattered among granuloma cells and in intimate contact with the deposited eggs were more predominant in the SEA group than in the infected control group. Concurrently, the counts of Mac-1 positive cells were significantly increased in liver sections of the SEA group than the infected control group during the course of infection. MIP-1alpha showed early higher counts followed by lower counts in the later stages of infection on granuloma cells in the SEA group than the infected control group. During the course of infection, similar distribution of Mac-1 and MIP-1alpha was present in both groups. This study suggests that sensitization with SEA probably leads to enhancement of phagocytic activity of macrophages via increasing expression of Mac-1 and hence engulfment of ic3b coated schistosomal products such as ova. It leads to rapid destruction of ova and hence decreases the host inflammatory response to infection and amelioration of hepatic pathology which would be a promising approach in reduction of host morbidity and mortality.


Subject(s)
Granuloma/immunology , Macrophage Inflammatory Proteins/biosynthesis , Macrophage-1 Antigen/biosynthesis , Schistosoma mansoni/immunology , Schistosomiasis mansoni/immunology , Animals , Antibodies, Monoclonal , Antigens, Helminth/immunology , Blotting, Western , Chemokine CCL3 , Chemokine CCL4 , Gene Expression Regulation , Granuloma/parasitology , Granuloma/pathology , Image Processing, Computer-Assisted , Immunohistochemistry , Liver/parasitology , Liver/pathology , Macrophage Inflammatory Proteins/analysis , Macrophage-1 Antigen/analysis , Mice , Mice, Inbred C57BL , Schistosomiasis mansoni/pathology
4.
APMIS ; 107(8): 723-36, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10515123

ABSTRACT

The anti-miracidial potential of recombinant Schistosoma mansoni glutathione S-transferase 26 (rSmGST26) or native crude soluble egg antigens (SEA) was assessed. The associated dynamics of granuloma formation and immune responses were evaluated. Naive C57BL/6 mice were injected intravenously with multiple doses of either SEA (SEA-group) or rSmGST26 (GST-group) 7 days before cercarial infection. The immunized groups and the respective controls were sacrificed 6, 8 and 16 weeks postinfection (p.i.). Acceleration of ova destruction and reduction of granuloma diameter were greater in the GST-group than the SEA-group, mainly at 8 weeks p.i. However, the amelioration of hepatic pathology and function was more evident in the SEA-group. Concurrently, serum-specific IgG1 levels were elevated throughout the course of infection in the immunized groups compared to the infected controls. Initial rise of all splenic cytokines and serum anti-SEA IgE levels at 6 weeks p.i. was observed, followed by a dramatic drop in the levels of the proinflammatory cytokines IL-2, IFNgamma, IL-4 and TNF-alpha and IgE at 8 weeks of infection. IL-10 level was lower at 8 weeks p.i. than at 6 weeks, but was higher in immunized groups than in infected controls. Several responses may be implicated as an outcome of the present immunization protocol, such as increased levels of blocking antibody (IgG1) and IL-10 with decreased levels of proinflammatory cytokines and IgE.


Subject(s)
Antigens, Helminth/immunology , Glutathione Transferase/immunology , Schistosoma mansoni/immunology , Schistosomiasis mansoni/prevention & control , Alanine Transaminase/blood , Animals , Antibodies, Helminth/immunology , Antigens, Helminth/therapeutic use , Cytokines/biosynthesis , Gene Expression , Glutathione Transferase/administration & dosage , Glutathione Transferase/therapeutic use , Immunoglobulin E/blood , Immunoglobulin G/blood , Immunoglobulin Isotypes , Mice , Mice, Inbred C57BL , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/isolation & purification , Recombinant Fusion Proteins/therapeutic use , Schistosoma mansoni/enzymology , Schistosomiasis mansoni/immunology , Schistosomiasis mansoni/pathology , Spleen/immunology , Vaccines/administration & dosage , Vaccines/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...